Cargando…
Metabolomics in endometriosis: challenges and perspectives for future studies
Endometriosis is a complex disease characterized by inflammation and the growth of endometrial- like glands and stroma outside the uterine cavity. The pathophysiology of endometriosis is not entirely understood, however, with a prevalence of ~10% of women in their reproductive years, the disease sym...
Autores principales: | Ortiz, Camila N, Torres-Reverón, Annelyn, Appleyard, Caroline B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812441/ https://www.ncbi.nlm.nih.gov/pubmed/35128453 http://dx.doi.org/10.1530/RAF-20-0047 |
Ejemplares similares
-
Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis
por: Torres-Reverón, Annelyn, et al.
Publicado: (2018) -
Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis
por: Torres-Reverón, Annelyn, et al.
Publicado: (2020) -
Efficacy of an environmental enrichment intervention for endometriosis: a pilot study
por: De Hoyos, Grace, et al.
Publicado: (2023) -
Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs
por: Pagán-Busigó, Joshua E., et al.
Publicado: (2022) -
Anxiety, coping skills and hypothalamus-pituitary-adrenal (HPA) axis in patients with endometriosis
por: Quiñones, Maria, et al.
Publicado: (2015)